Term
What diseases are higher in which gender? |
|
Definition
Women - chlamydia 3x - gonorrhea 2x higher
Men - syphilis 6x higher |
|
|
Term
|
Definition
3 out of 4: Presence of homogenous grey/white DC that coats vaginal walls Presence of clue cells on wet prep pH > 4.5 Positive whiff test on KOH prep |
|
|
Term
|
Definition
Location Single vs. Grouped Border-regularity, diffuse, raised Tenderness Consistency Lymphandenopathy |
|
|
Term
Types of genital ulcers (3) |
|
Definition
Herpes Virus Molluscum Contagiosum Syphilis |
|
|
Term
|
Definition
◦ Vulva, cervix, vagina, buttocks ◦ Glans, shaft of penis, scrotum, perianal |
|
|
Term
Primary herpes infection characteristics |
|
Definition
◦ Flu-like syndrome (Fever, arthralgias, headache, inguinal lymphadenopathy) ◦ Prodrome—Itching and burning ◦ Blister eruption ◦ Painful urination ◦ Monitor for Urinary retention ◦ Grouped shallow lesions, exquisitely tender |
|
|
Term
Asymptomatic herpes tests |
|
Definition
ELISA and western blot Tests for HSV-1 and HSV-2 12-26 weeks post exposure Sensitivity 80-98% Specificity 97-100% Confirmatory testing may be indicated in some settings |
|
|
Term
|
Definition
◦ Acyclovir 400 mg three times a day ◦ Acyclovir 200 mg five times a day ◦ Famciclovir 250 mg three times a day ◦ Valacyclovir 1000 mg twice a day ** x 7-10 days |
|
|
Term
Herpes episodic therapy (7) |
|
Definition
Acyclovir 400 mg three times daily x 5 days or Acyclovir 800 mg twice daily times daily x 5 days or Acyclovir 800 mg three times daily x 2 days or Famciclovir 125 mg twice daily x 5 days or Famciclovir 1000 mg twice daily x 1 day or Valacyclovir 500 mg twice daily x 3 days or Valacyclovir 1 gm orally daily x 5 days |
|
|
Term
Herpes suppression therapy daily (3) |
|
Definition
Acyclovir 400 mg twice a day or Famciclovir 250 mg twice a day or Valacyclovir 500-1000 mg daily |
|
|
Term
Treatment for molluscum contagiosum |
|
Definition
Trichloracetic acid cryotherapy |
|
|
Term
|
Definition
Primary (9-90 days post exposure) Secondary (6 wks- 6 mos. Post exposure)
Latent (non-infectious except in pregnancy) Early (< one year post exposure) Late (> one Year post exposure) Tertiary (advanced disease) |
|
|
Term
|
Definition
Chancre ◦ 1-3 weeks post exposure Painless Ulcer Indurated Raised borders - labial chancre - sometimes undetected |
|
|
Term
|
Definition
Systematic Disease Occurs 6 weeks to 6 months following healing of Chancre Generalized lesions of the skin and mucus membranes (rashes, especially palmar and plantar, condyloma lata) Alopecia Papulosquamous rash occurs anywhere on body, including face, trunk, palmar and plantar surfaces |
|
|
Term
|
Definition
Nontreponemal (Screening Tests) VDRL, RPR Titers Correlate with disease activity High False positives
Treponemal FTA-ABS or MHA-TP 75% Reactive for lifetime regardless of treatment |
|
|
Term
Syphilis Definitive diagnosis |
|
Definition
Darkfield Examination (microscopic) Direct fluorescent antibody tests CSF |
|
|
Term
Syphilis - primary, secondary, early latent treatment |
|
Definition
Recommended Regimen Benzathine Penicillin G1 2-4 million units IM
Penicillin Allergy* Doxycycline 100 mg twice daily x 14 days or Ceftriaxone 1 gm IM/IV daily x 8-10 days (limited studies) or Azithromycin 2 gm single oral dose (preliminary data)
*Use in HIV-infection has not been studied |
|
|
Term
|
Definition
Benzathine penicillin G 2.4 million units IM at one week intervals x 3 does. Clinical follow up =quantitative VDRL titers and exam at 3, 6 and 12 months Penicillin allergy* Doxycycline 100 mg orally twice daily or Tetracycline 500 mg orally four times daily for 28 days |
|
|
Term
Gonorrhea symptoms - male |
|
Definition
Usually symtomatic Purulent Urethral discharge Dysuria
Complications Epididymitis Urethral Stricture Disseminated GC |
|
|
Term
Gonorrhea symptoms - female |
|
Definition
Up to 80% have no sx Abnormal vaginal discharge Abnormal menses Pelvic pain Dysuria
Complications PID Infertility Disseminated GC |
|
|
Term
|
Definition
- ceftriaxone 250 mg x 1 IM - PLUS either azithromycin 1 g PO x 1 - OR doxycycline 100 mg PO BID x 7 days |
|
|
Term
Women have no symptoms for what disease? |
|
Definition
- gonorrhea, chlamydia, HPV, HSV |
|
|
Term
|
Definition
Indirect – DNA Probe Direct – Tissue Culture
Urine- Nucleic acid amplification test |
|
|
Term
|
Definition
Azithromycin 1 g orally in a single dose OR Doxycycline 100 mg orally twice a day for 7 days Encourage partner delivered therapy |
|
|
Term
PID - predisposing factors |
|
Definition
Sexually Active Multiple partners History of STIs Age Under 25 Recent Instrumentation IUD Insertion D&C |
|
|
Term
|
Definition
Abnormal vaginal discharge (different from usual cyclic changes related to menses) Spotting, especially post-coital Pain with intercourse (dyspareunia) Vague, intermittent abdominal pain Often asymptomatic (important to screen persons with high risk behaviors) Low grade fever |
|
|
Term
|
Definition
Ceftriaxone 250 mg IM in a single dose PLUS Doxycycline 100 mg orally twice a day for 14 days WITH or WITHOUT Metronidazole 500 mg orally twice a day for 14 days |
|
|
Term
|
Definition
Cefotetan 2 g IV every 12 hours OR Cefoxitin 2 g IV every 6 hours PLUS Doxycycline 100 mg orally or IV every 12 hours |
|
|
Term
|
Definition
cauliflower-shaped growths with granular surface and fingerlike projections |
|
|
Term
|
Definition
smooth, skin colored, well-circumscribed papules; no fingerlike projections |
|
|
Term
|
Definition
|
|
Term
|
Definition
◦ Lesions appear 2-3 months after infection, with range of 3 weeks to 8 months |
|
|
Term
|
Definition
Hybrid Capture II assay captures 13 different high risk types HPV DNA testing recommended only with cervical cancer screening |
|
|
Term
|
Definition
Goal – eradicate or reduce the size of apparent warts Reasonable not to delay treatment unless warts persist or enlarge given that they may resolve spontaneously Patient applied – Imiquimod 5% cream Clinician applied – TCA and cryotherapy most common Cervical – refer to OBGYN Vaginal – cryotherapy or TCA Urethral - cryotherapy Anal - cryotherapy Oral - cryotherapy |
|
|
Term
|
Definition
Series of 3 shots over 6 months Cervarix (Types 16 & 18) and Gardasil (Types 6, 11, 16, & 18) available Females: Gardasil prevents cervical, vulvar, and vaginal cancer; genital warts; and anal cancer Males: Gardasil prevents anal cancer and genital warts Available age 11-26 for females and 11-21 for males |
|
|